JUBEREQ

Product NDC
69448-022
11-digit product format
694480022
Labeler code
69448
Product ID
69448-022_caa201eb-143f-4390-9788-894e1810fee8
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
denosumab-desu
Dosage form
INJECTION
Route
SUBCUTANEOUS
Labeler
Accord BioPharma Inc.
Application
BLA761424
Marketing category
BLA
Marketing start
2026-07-13
Substance
DENOSUMAB
Active strength
70 mg/mL
Pharmacologic classes
RANK Ligand Blocking Activity [MoA]; RANK Ligand Inhibitor [EPC]
Listing certified through
2027-12-31
Current FDA listing
Yes

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
JUBEREQDENOSUMAB-DESUAccord BioPharma Inc.e15dfe74-1575-4a2a-895e-323c056133622026-07-14Warnings, Adverse reactionsExact identifier
application number: BLA761424
ndc (product): 69448-022
OSVYRTIDENOSUMAB-DESUAccord BioPharma Inc.5f3be096-5100-4d0e-b765-481bbb2672e12026-07-07Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA761424

Additional Listing Data#

Finished product
Yes
Brand name base
JUBEREQ
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
DENOSUMAB70 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
4EQZ6YO2HIInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 2 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2747255Internal RxNorm lookup
2747262Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
e15dfe74-1575-4a2a-895e-323c05613362Available on FDA.report

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761424Osvyrtidenosumab-desu351(k) InterchangeableRx2026-06-01

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleStatus
69448-022-63694480022631 VIAL, SINGLE-USE in 1 CARTON (69448-022-63) / 1.7 mL in 1 VIAL, SINGLE-USE2026-07-130Current